http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03167191-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C333-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C333-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
filingDate 1990-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b047ba3c8b7147dfdc323e4adf14e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280b6a2189992882507b569e404cb3fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1025fdc8926d366c6badb1eb8d333b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee0aa45f1fb6b3731682542b2db61439
publicationDate 1991-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03167191-A
titleOfInvention Isothiazolo-quinoline derivative and neoplastic agent containing the same
abstract Isothiazolo-quinoline derivatives of the formula I which may exist as tautomers (formula II) are described which are cytotoxic for various tumor cell lines and are useful in the treatment of neoplastic diseases. <CHEM> wherein R is selected from (a) lower alkyl, (b) haloalkyl, (c) lowercycloalkyl, (d) alkylamino, (e) an aromatic heterocyclic group and (f) a phenyl group; W, X and Z are independently selected from hydrogen, halogen and lower alkyl; and Y is selected from a (a) phenyl group, (b) -NR2R3, (c) a bicyclic N-containing heterocyclic group, and (d) -OR10, wherein R10 is hydrogen, lower alkyl or a phenyl group; or any two of W, X, Y and Z taken together form a fused, substituted or unsubstituted, aromatic group or heterocyclic group.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9216444-B2
priorityDate 1989-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234635499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159353

Total number of triples: 32.